CoreBone
Misgav
About CoreBone
CoreBone has developed a highly bioactive, 100% mineral, strong bone graft material for dental, orthopedic and spine applications. The patented technology embeds bioactive minerals (e.g., silicium) into the skeleton of corals during their growth process, accelerating healing and providing better bone connectivity. CoreBone was founded by CEO Ohad Schwartz and CTO Prof. Itzhak Binederman. It is one of the portfolio companies of The Trendlines Group. CoreBone has issued patents and substantial know-how in regard to growing coral for medical purposes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.7M
- Last round: Series Unknown (Oct 2021)
- Website: core-bone.com
- Phone: [email protected]
Industries & Categories
Health Care, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/corebone-93001 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.